Metaboolne fragment

HGH Fragment 176-191 kalkulaator

Arvuta iga peptiidi jaoks täpsed lahuse mahud, insuliiniühikud ja annuste arv viaali kohta.

Viaal, vesi ja annus on teada

HGH Fragment 176-191See kalkulaator on seatud peptiidile HGH Fragment 176-191

Peptiidi kogus (mg)

BAC-vesi (ml)

Annus (mcg)

tavaline 100-500 mcg

mcgmg

Süstla suurus

Kalibreerimine

U-100U-40

Ühikud on maht, mitte toimeaine

Ühikud mõõdavad mahtu, mitte toimeainet. 5 IU = 0,05 ml. Mitu mg selles on, sõltub segust. Kalkulaator on selle sinu eest välja arvutanud.

Peaaegu kõik insuliinisüstlad on U-100. Vali U-40 ainult siis, kui süstal on tähistatud U-40.

Sinu tulemus · reaalajas

IUmlÜhikud

Tõmba süstlasse

5IU

5 IU / 100 IU (0.050 ml)

Kontsentratsioon

5.00

mg/ml

Maht annuse kohta

0.050

Annuseid viaali kohta

annust

annuse kohta

—

HGH Fragment 176-191

Põhiandmed

Sagedus: 1–2x daily
Tavaline vahemik: 100-500 mcg

Teadusprofiil

HGH Fragment 176-191 peptiidileksikonis: mehhanism, tõendus ja allikad

→

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is a synthetic peptide composed of 16 amino acids that reproduces the C-terminal region of human growth hormone (somatropin). The intact growth hormone molecule contains 191 amino acids, and research conducted in the 1990s identified that the hormone's fat-burning properties are concentrated in a well-defined stretch spanning amino acids 176 through 191. This specific segment was isolated, synthetically reproduced, and stabilized for research purposes. The "176-191" designation therefore points directly to the position of this sequence within the full hormone molecule.

The central idea behind this fragment is functional separation. Whereas intact growth hormone exerts a wide range of effects on the organism — including growth, tissue building, and a marked rise in IGF-1 — HGH Fragment 176-191 isolates only the lipolytic (fat-mobilizing) portion. In preclinical models, the fragment was shown to stimulate fat breakdown without triggering the growth-promoting and glucose-related effects characteristic of full growth hormone to the same degree. For this reason, HGH Fragment 176-191 is frequently described in research as the "lipolytic fragment" of growth hormone.

HGH Fragment 176-191 is closely related to AOD-9604, another derivative of the same C-terminal region. AOD-9604 is a modified variant in which an additional tyrosine residue improves stability, and both compounds are discussed within the same metabolic research context. Importantly, the fragment is not a secretagogue: it does not stimulate the body's own release of growth hormone but acts directly on fat cells. This sets it apart fundamentally from GHRH analogs and ghrelin mimetics, which work through the pituitary. All information presented here relates strictly to the research context.

Mechanisms of Action

HGH Fragment 176-191 exerts its effects primarily by influencing fat metabolism in adipocytes (fat cells). The mechanisms investigated in research can be summarized as follows:

Stimulation of lipolysis: The fragment promotes the breakdown of triglycerides stored in fat cells into free fatty acids and glycerol. This process makes stored energy available for further metabolism and forms the core of the peptide's lipolytic activity.
Inhibition of lipogenesis: Alongside promoting fat breakdown, the fragment reduces the formation of new fat tissue in preclinical models by dampening the conversion of dietary components into new fat stores. The combined effect of increased breakdown and reduced buildup shifts the balance of fat metabolism.
Increased fat oxidation: Beyond simply releasing fatty acids, animal models suggest the fragment increases the actual burning of those fatty acids for energy. This is important, because released fatty acids could otherwise be re-stored in fat cells if not followed by oxidation.
No relevant rise in IGF-1: Unlike intact growth hormone, the fragment does not produce a pronounced increase in insulin-like growth factor 1 (IGF-1) in the research literature. As a result, the growth-promoting effects associated with IGF-1 are largely absent, which is considered a key distinction from the full hormone.
Limited effect on blood glucose: Full growth hormone can impair insulin sensitivity and raise blood sugar. HGH Fragment 176-191 showed a markedly smaller influence on glucose metabolism in preclinical studies, because the diabetogenic portion of the hormone lies outside the 176-191 sequence.
No action through the growth axis: The fragment does not bind the classical growth hormone receptor in a way that drives tissue growth, and it does not stimulate the pituitary. Its activity remains focused on fat metabolism, which explains its relatively narrow profile.

In summary, HGH Fragment 176-191 is intended to decouple the fat-mobilizing properties of growth hormone from its growth-related and metabolic side effects. Whether this theoretical profile holds up in robust human clinical data remains the subject of ongoing research.

Dosage Calculation

HGH Fragment 176-191 is dosed in micrograms (mcg) in the research context. Because the peptide has a short half-life, many protocols use a divided daily dose. Slow titration is generally not required, though starting at the lower end of the range is a reasonable precaution.

Standard Dosing Parameters

Conservative dose: 100 mcg (0.10 mg) per injection
Standard dose: 250 mcg (0.25 mg) per injection
Higher range: 400–500 mcg (0.40–0.50 mg) per injection
Frequency: Once or twice daily, with many protocols dosing in a fasted state in the morning and optionally before physical activity
Half-life: Approximately 2.5 hours, which explains the common practice of splitting the daily amount into several smaller doses
Typical syringe: 0.3 mL insulin syringe (29–31 gauge, 6–8 mm needle)

Example Calculation: 10 mg Vial with 2 mL BAC Water

A common vial size for HGH Fragment 176-191 is 10 mg. Adding 2 mL of bacteriostatic water gives a concentration of 5 mg/mL (5,000 mcg/mL).

100 mcg dose: 100 ÷ 5000 = 0.02 mL (2 units on a U100 syringe)
250 mcg dose: 250 ÷ 5000 = 0.05 mL (5 units)
400 mcg dose: 400 ÷ 5000 = 0.08 mL (8 units)
500 mcg dose: 500 ÷ 5000 = 0.10 mL (10 units)

At 250 mcg once daily, a 10 mg vial provides 40 days of dosing; at two 250 mcg doses per day, it lasts 20 days. Because small volumes are especially error-prone here, precise calculation is worthwhile. Use the HGH Fragment 176-191 calculator above to determine accurate volumes for any vial size, reconstitution volume, and target dose.

Injection Site and Timing Selection

HGH Fragment 176-191 is typically injected subcutaneously into the abdominal fat layer. Because the lipolytic effect is mediated systemically, targeting a specific fat depot with the injection is not necessary, and localized injection does not produce spot reduction of fat. Many research protocols time administration to a fasted state — for example, in the morning before the first meal — since a low insulin level favors lipolysis. Rotating injection sites reduces local irritation.

Reconstitution

HGH Fragment 176-191 is supplied as a lyophilized (freeze-dried) powder in sealed vials. It must be reconstituted with bacteriostatic water (BAC water) before use. BAC water contains 0.9% benzyl alcohol, which inhibits microbial growth and extends the usable window of the reconstituted solution. Sterile water for injection is less suitable for multi-dose vials because it contains no preservative.

Step-by-Step Reconstitution Protocol

Gather supplies: the HGH Fragment 176-191 vial, a vial of bacteriostatic water, alcohol swabs, a sterile draw needle (18–21 gauge), and your insulin syringe for injection.
Wipe the rubber septa of both vials with fresh alcohol swabs and allow them to air-dry for about 30 seconds. Do not touch or blow on the septa afterward.
Draw the desired volume of BAC water into the draw syringe. For a 10 mg vial, 2 mL is a common starting point that simplifies dose calculation.
Insert the needle into the peptide vial at an angle, directing the tip toward the inner glass wall rather than the powder cake. A direct stream of water onto the lyophilized powder can mechanically stress the delicate peptide bonds.
Slowly push the plunger so the BAC water runs down the inner glass wall and gently wets the powder from below.
Gently roll or swirl the vial between your palms until the powder is completely dissolved. The finished solution should appear clear and colorless. Do not shake or vortex the vial.
Label the vial with the reconstitution date and concentration, for example "HGH Fragment 176-191 5 mg/mL — reconstituted [date]".

If the solution appears cloudy, discolored, or contains visible particulate matter, the vial should be discarded and not used.

Storage and Shelf Life

Lyophilized powder (unreconstituted): Store at −20°C for long-term storage, where the powder remains stable for many months. Short-term storage at 2–8°C in a refrigerator is acceptable. Protect from light and moisture, and do not leave at room temperature for extended periods.
Reconstituted solution: Store in the refrigerator at 2–8°C and use within approximately 28–30 days. Keep the vial upright and away from light. Write the reconstitution date prominently on the label and discard the vial once the window has elapsed, regardless of remaining volume.
Do not freeze reconstituted peptide. Freeze-thaw cycles cause protein aggregation and a loss of biological activity. Once reconstituted, the vial must remain refrigerated throughout its use window.
Transport: Use an insulated cooler with an ice pack for any travel lasting more than one to two hours. Commercial insulated medication pouches maintain 2–8°C for 24–48 hours. Avoid exposure to temperatures above 25°C during transport.

Side Effects and Safety Profile

HGH Fragment 176-191 is described in preclinical research as generally well tolerated, particularly because of its narrower profile compared with full growth hormone. Since human clinical data is limited, all use remains in the research domain, and a definitive safety verdict is not possible.

Commonly Reported Observations

Mild redness, transient swelling, or brief discomfort at the injection site. These local reactions usually resolve within a few hours, and rotating injection sites reduces irritation.
Temporary fatigue or a sensation of hunger, which some users report with fasted use and which is associated with the mobilization of energy reserves.
An occasional flushing sensation or mild lightheadedness shortly after injection, which typically subsides quickly.

Less Common or Theoretical Concerns

Effect on blood glucose: Although the fragment is expected to influence glucose metabolism far less than full growth hormone, complete neutrality is not guaranteed. Individuals with impaired glucose metabolism should take this into account.
Allergic reactions: As with any injectable peptide, hypersensitivity reactions to the active compound or to the benzyl alcohol in BAC water are theoretically possible.
Limited long-term data: No extensive long-term human studies are available. The effects of sustained use over long periods are not adequately characterized.

Contraindications

Pregnancy and breastfeeding, due to a lack of robust safety data
Known hypersensitivity to the peptide or any component of the preparation
Active cancer without medical supervision

No serious adverse events specifically attributable to HGH Fragment 176-191 have been described in the available literature at standard research doses. Given the absence of large-scale human studies, caution is warranted, and consultation with a qualified healthcare professional is strongly recommended.

Combinations and Stacks

HGH Fragment 176-191 and AOD-9604

Because AOD-9604 is a closely related, stabilized variant of the same C-terminal region, the two compounds are generally regarded in research as alternatives rather than a stack to be used simultaneously. Those who want to examine the metabolic research question from two angles compare the profiles of the two fragments rather than combining them.

HGH Fragment 176-191 and GH Secretagogues

In practice, the fragment is frequently discussed in connection with peptides of the growth hormone axis. Secretagogues such as Ipamorelin or GHRH analogs such as CJC-1295 without DAC work through the body's own release of growth hormone, and therefore through a fundamentally different mechanism than the fragment, which acts directly on fat cells. The conceptual appeal of this combination lies in its complementarity: one element targets the hormone level, the other targets fat metabolism itself. Dosing details for these peptides are available in their respective calculators.

HGH Fragment 176-191 and Tesamorelin

Tesamorelin is a GHRH analog discussed in research specifically in connection with visceral fat tissue. Because Tesamorelin works through the growth hormone axis while the fragment acts directly through lipolysis, the two compounds address different levels of fat metabolism. The relevant parameters can be reviewed using the Tesamorelin calculator.

Frequently Asked Questions

How does HGH Fragment 176-191 differ from real growth hormone?

Real growth hormone is a complete 191-amino-acid protein with a broad range of effects, including growth, tissue building, and a marked rise in IGF-1. HGH Fragment 176-191, by contrast, reproduces only the C-terminal region in which the fat-mobilizing activity is located. The fragment is therefore intended to stimulate lipolysis without triggering the growth-promoting and glucose-related effects of the full hormone to the same extent.

Does the fragment raise IGF-1 levels?

According to the available preclinical literature, HGH Fragment 176-191 does not produce a pronounced increase in IGF-1. This property is considered a central distinguishing feature compared with intact growth hormone, since the hormone's growth-promoting effects are largely mediated through IGF-1.

Is the fragment a GH secretagogue?

No. A secretagogue stimulates the pituitary to release more of the body's own growth hormone. HGH Fragment 176-191 works differently: it acts directly on fat metabolism in the adipocytes and does not stimulate the pituitary. This sets it apart fundamentally from peptides such as Ipamorelin or GHRH analogs.

Why is the fragment often used in a fasted state?

A low insulin level favors lipolysis, while an elevated insulin level dampens fat mobilization. For this reason, many research protocols time administration to a fasted state — for example, in the morning before the first meal or before physical activity — so that the fat-mobilizing effect is not blunted by a concurrent meal.

Does injecting into a specific body area cause local fat loss?

No. The effect of HGH Fragment 176-191 is mediated systemically. Injecting into the abdomen or another region does not produce targeted breakdown of fat tissue at that site. The choice of injection site is therefore based on practical considerations rather than a desire for a localized effect.

How do HGH Fragment 176-191 and AOD-9604 differ?

Both compounds are derived from the same C-terminal region of growth hormone. AOD-9604 is a modified variant in which an additional tyrosine residue improves the stability of the sequence. HGH Fragment 176-191, by contrast, corresponds to the unmodified fragment sequence. In research, both are considered within the same metabolic context and are usually compared as alternatives.

Why is the fragment often dosed several times per day?

The half-life of HGH Fragment 176-191 is approximately 2.5 hours, so the peptide is cleared from the circulation relatively quickly. To achieve more even exposure across the day, many protocols split the daily amount into one or two smaller doses rather than administering it in a single dose.

Where can I buy HGH Fragment 176-191?

Medical Disclaimer: The information on this page is provided for educational and research purposes only. HGH Fragment 176-191 is not an approved drug or medical treatment and is sold strictly for research use. Nothing on this page constitutes medical advice, diagnosis, or a recommendation to use any specific compound. Always consult a qualified healthcare professional before beginning any peptide protocol. BergdorfBio assumes no liability for the use or misuse of the information presented here.

Samm-sammult

Kuidas peptiidi lahustada

Pulbrist valmis süstlani viie sammuga. Ülalolev kalkulaator annab kogused automaatselt.

011
Valmista BAC-vesi ette
Lase viaalil ja veel jõuda toatemperatuurini. Pühi mõlemad kummikorgid alkoholilapiga.
022
Tõmba vesi süstlasse
Tõmba kalkulaatori soovitatud BAC-vee kogus suurema süstlaga.
033
Lisa aeglaselt
Lase veel voolata mööda peptiidiviaali siseseina, ära pihusta seda otse pulbrile.
044
Lase lahustuda
Keeruta viaali õrnalt, ära raputa. Pulber lahustub selgeks 1-2 minuti jooksul.
055
Tõmba annus süstlasse
Tõmba insuliinisüstlaga täpselt arvutatud kriipsuni. Valmis.

Viide

Annused ja viaalisuurused peptiidi kaupa

Tavalised algväärtused orienteerumiseks. Iga rida avab selle peptiidi kalkulaatori.

Peptiid	Kategooria	Tavaline annus	Viaalisuurused	BAC (algus)	Saadaval	Arvuta
VIP	Neuropeptiidide uurimine	-	10 mg	2 ml	Ainult kalkulaator	Arvuta
Retatrutide	GLP-1/GIP/GCG	0,5-12 mg	2 / 5 / 10 / 15 mg	2 ml	Ainult kalkulaator	Arvuta
Cagrilintide	Amüliini analoog	-	5 mg	2 ml	Ainult kalkulaator	Arvuta
Semaglutide	GLP-1	0,25-2,4 mg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Tirzepatide	GLP-1/GIP	2,5-15 mg	10 / 15 / 20 / 30 / 60 / 90 mg	2 ml	Ainult kalkulaator	Arvuta
GHK-Cu	Vaskepeptiid	1-4 mg	10 / 20 / 50 mg	5 ml	Ainult kalkulaator	Arvuta
AHK-Cu	Vaskepeptiid	-	100 mg	5 ml	Ainult kalkulaator	Arvuta
BPC-157	Kudede taastamine	0,2-0,5 mg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
TB-500	Thymosin Beta-4	2-5 mg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
CJC-1295 (ilma DAC-ta)	GHRH analoog	100-200 mcg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Ipamorelin	GHRP	200-300 mcg	2 / 5 mg	2 ml	Ainult kalkulaator	Arvuta
AOD-9604	Rasvade ainevahetus	250-500 mcg	2 / 5 mg	2 ml	Ainult kalkulaator	Arvuta
PT-141	Bremelanotide	-	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
MOTS-c	Mitokondriaalne	5-10 mg	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Selank	Anksiolüütiline	150-500 mcg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
SS-31	Elamipretide	0,1-1 mg	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Glow Stack	Stack	0,5-2 mg	70 mg	3 ml	Ainult kalkulaator	Arvuta
Klow Stack	Stack	0,5-2 mg	55 mg	3 ml	Ainult kalkulaator	Arvuta
Melanotan II	Melanokortiin	100-1000 mcg	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Melanotan I	Melanokortiin	-	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Sermorelin	GHRH analoog	50-300 mcg	5 mg	2 ml	Ainult kalkulaator	Arvuta
Tesamorelin	GHRH analoog	1-2 mg	10 / 20 mg	2 ml	Ainult kalkulaator	Arvuta
Thymosin Alpha-1	Tüümusepetiid	0,8-3,2 mg	1.6 / 5 / 10 mg	1 ml	Ainult kalkulaator	Arvuta
Epithalon	Pikaajalisus	2-10 mg	10 / 20 / 50 mg	2 ml	Ainult kalkulaator	Arvuta
KPV	Immuunsüsteem / barjäär	100-1000 mcg	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
HGH Fragment 176-191	Metaboolne fragment	100-500 mcg	2 / 5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Semax	Kognitiivne	100-1000 mcg	10 / 30 mg	2 ml	Ainult kalkulaator	Arvuta
N-Acetyl Semax	Kognitiivne	100-1000 mcg	5 / 10 mg	2 ml	Ainult kalkulaator	Arvuta
Hexarelin	GHRP	50-200 mcg	2 / 5 mg	2 ml	Ainult kalkulaator	Arvuta
GHRP-6	GHRP	50-300 mcg	2 / 5 mg	2 ml	Ainult kalkulaator	Arvuta
GHRP-2	GHRP	50-250 mcg	2 / 5 mg	2 ml	Ainult kalkulaator	Arvuta
DSIP	Uni	50-500 mcg	10 mg	2 ml	Ainult kalkulaator	Arvuta
5-Amino-1MQ	Metaboolne	2,5-10 mg	10 mg	2 ml	Ainult kalkulaator	Arvuta
Pinealon	Uurimispeptiid	-	10 mg	2 ml	Ainult kalkulaator	Arvuta
Survodutide	GLP-1/glükagoon	-	10 mg	2 ml	Ainult kalkulaator	Arvuta
Kisspeptin-10	KISS1R / GPR54	-	10 mg	2 ml	Ainult kalkulaator	Arvuta
HGH 191AA	Kasvuhormoon	1-5 mg	10 mg	1 ml	Ainult kalkulaator	Arvuta
NAD+	Pikaajalisus / kofaktor	100-500 mg	1000 mg	10 ml	Ainult kalkulaator	Arvuta

Väärtused on mõeldud orienteerumiseks uurimiskontekstis ega asenda professionaalset nõuannet.

Miks täpne annustamine oluline on

Kontsentratsiooni ja süstemahu õige arvutamine tundub tühine, kuid on kõige sagedasem veaallikas. Isegi 10 % suurune arvutusviga lahuse valmistamisel tähendab, et saad kas liiga vähe toimeainet või manustad kogemata üleannuse.

Lüofiliseeritud peptiide müüakse milligrammides ja need lahustatakse bakteriostaatilises vees (BAC-vesi). Peptiidi ja vee suhe määrab kontsentratsiooni ja sellest tuleneb, mitu ühikut insuliinisüstlale tõmbad. Insuliinisüstlaid gradueeritakse ühikutes, mitte milligrammides. Kalkulaator teeb selle ümberarvutuse ära, sealhulgas mõistlikkuse kontrolli kõige ohtlikuma vea vastu: mg ja mcg segiajamine.

KKK

Korduma kippuvad küsimused

Mis vahe on mcg ja mg vahel?

Milligramm (mg) on ühik, milles lüofiliseeritud peptiide müüakse, näiteks „5 mg BPC-157". Mikrogramm (mcg) mõõdab üksikannust, näiteks „250 mcg süsti kohta". 1 mg = 1000 mcg. Kalkulaator teeb ümberarvutuse automaatselt ja hoiatab, kui sisestus tundub segiaetud olevat.

Mida tähendab „U-100" minu insuliinisüstlal?

U-100 tähendab, et süstal on kalibreeritud 100 ühikule milliliitri kohta. 100 IU = 1 ml, seega 10 IU = 0,10 ml, sõltumata sellest, mis süstlas on. IU arvutus põhineb täpselt sellel seosel.

Miks näitab kalkulaator mõnikord väga väikeseid mahtusid?

Palju peptiidi ja vähe vett teeb lahuse väga kontsentreerituks, mistõttu maht annuse kohta on tilluke ja raskesti loetav. Kasuta segamise abivahendit: see leiab veekoguse, millega tekib puhas ja hästi loetav kriips.

Kui kaua lahustatud peptiid püsib?

Külmkapis 2-8 °C juures tavaliselt 21-30 päeva. Märgista viaalile lahuse valmistamise kuupäev. Hägused lahused või osakesed ei kõlba.

Kuidas kalkulaator töötab segude, näiteks Glow Stacki puhul?

Segud sisaldavad ühes viaalis mitut toimeainet. Vali peptiidiks lihtsalt segu: kalkulaator näitab lisaks, kui palju igat komponenti sinu süstis on. Mitme eraldi viaali kombinatsiooni jaoks kasuta Stack Builderit.

Kas kalkulaator tuleb iga kord uuesti täita?

Ei. Sinu viimased seaded salvestatakse lokaalselt brauserisse ja taastatakse järgmisel külastusel. Arvutusi saad ka ajaloost tagasi kutsuda, protokollina salvestada või lingina jagada.

Seotud peptiidid

AOD-9604Rasvade ainevahetus IpamorelinGHRP TesamorelinGHRH analoog

Kõik kalkulaatorid

Vali peptiid

Vali peptiid, et avada selle kalkulaatorileht eeltäidetud väärtustega.

HGH Fragment 176-191 kalkulaator

Põhiandmed

What Is HGH Fragment 176-191?

Mechanisms of Action

Dosage Calculation

Standard Dosing Parameters

Example Calculation: 10 mg Vial with 2 mL BAC Water

Injection Site and Timing Selection

Reconstitution

Step-by-Step Reconstitution Protocol

Storage and Shelf Life

Side Effects and Safety Profile

Commonly Reported Observations

Less Common or Theoretical Concerns

Contraindications

Combinations and Stacks

HGH Fragment 176-191 and AOD-9604

HGH Fragment 176-191 and GH Secretagogues

HGH Fragment 176-191 and Tesamorelin

Frequently Asked Questions

How does HGH Fragment 176-191 differ from real growth hormone?

Does the fragment raise IGF-1 levels?

Is the fragment a GH secretagogue?

Why is the fragment often used in a fasted state?

Does injecting into a specific body area cause local fat loss?

How do HGH Fragment 176-191 and AOD-9604 differ?

Why is the fragment often dosed several times per day?

Where can I buy HGH Fragment 176-191?

Kuidas peptiidi lahustada

Valmista BAC-vesi ette

Tõmba vesi süstlasse

Lisa aeglaselt

Lase lahustuda

Tõmba annus süstlasse

Annused ja viaalisuurused peptiidi kaupa

Miks täpne annustamine oluline on

Korduma kippuvad küsimused

Seotud peptiidid

Vali peptiid

VIP

Retatrutide

Cagrilintide

Semaglutide

Tirzepatide

GHK-Cu

AHK-Cu

BPC-157

TB-500

CJC-1295 (ilma DAC-ta)

Ipamorelin

AOD-9604

PT-141

MOTS-c

Selank

SS-31

Glow Stack

Klow Stack

Melanotan II

Melanotan I

Sermorelin

Tesamorelin

Thymosin Alpha-1

Epithalon

KPV

Semax

N-Acetyl Semax

Hexarelin

GHRP-6

GHRP-2

DSIP

5-Amino-1MQ

Pinealon

Survodutide

Kisspeptin-10

HGH 191AA

NAD+

HGH Fragment 176-191 kalkulaator

Põhiandmed

What Is HGH Fragment 176-191?

Mechanisms of Action